Recent targeted screening efforts have identified the DNA translocase SMARCAL1 as a factor inhibiting the immune response of tumor cells due to its dual role in restricting innate immune signaling and upregulating PD-L1 levels10. The gene discussed is SMARCAL1; the disease is neoplasm.